Welcome to our in situ tumor model research platform, meticulously designed for pre-clinical evaluations of oncological drugs. We offer a range of detailed models that closely simulate the growth environments of tumors in various organs, ensuring the accuracy and realism of drug assessments.
Platform Features and Applications:
• Renal Capsule Tumor Model: Utilizes tumor chunk inoculation with evaluations conducted through clinical observations and in vivo imaging.
• Brain Tumor Model: Employs cell suspension inoculation methods, with evaluations based on clinical observations and in vivo imaging.
• Lung Tumor Model: Uses cell suspension inoculation, primarily assessed through in vivo imaging.
• Lung Tumor Model (Via Airway): Implemented with cell suspension inoculation, primarily evaluated using in vivo imaging.
• Breast Tumor Model (Mammary Fat Pad Inoculation): Utilizes cell suspension inoculation, with measurements taken using calipers.
• Liver Tumor Model: Uses tumor chunk inoculation, with evaluations encompassing palpation, in vivo imaging, and AFP level measurements.
• Pancreatic Tumor Model: Employs tumor chunk inoculation, with evaluations based on clinical observations and satellite tissue observations.
• Colorectal Tumor Model: Utilizes both tumor chunk and cell suspension inoculation methods, with evaluations including clinical observations and satellite tissue observations.
• Systemic Inoculation Tumor Model (Tail Vein): Employs cell suspension inoculation, with evaluations based on clinical observations and in vivo imaging.
• Prostate Tumor Model: Uses both tumor chunk and cell suspension inoculation methods, primarily assessed through in vivo imaging.
Note: All the above in situ tumor models can utilize tumor cell line models or the iHuPDX models from innoModels Technologies.
Our in situ tumor model research platform integrates a variety of experimental techniques and methods, offering comprehensive support for your oncological drug research and development. Should you have any questions or require further insights, please don't hesitate to contact us.